Navigation Links
Tiny radioactive spheres effectively treat cancer that has spread to the liver
Date:10/29/2007

JACKSONVILLE, Fla. − Placing tiny radioactive spheres directly into the liver through its blood supply halted growth of tumors that had spread to the organ in 71 percent of patients tested in a small clinical trial, researchers from Mayo Clinic Jacksonville report.

They say that the technique appears to offer a treatment option for patients who develop multiple tumors in their liver from cancer metastasis.

Most of these patients dont have other effective treatment options, because surgery is not possible if there are multiple tumors in their liver, says the studys lead investigator, Laura Vallow, M.D. But with this radiotherapy, no new tumors developed in patients who responded and we find this to be very encouraging.

Vallow presented results of the study at the annual meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO).

She says her report is one of the first to sum up an initial clinical experience with the therapy, known as SIR-Spheres microspheres, which was approved for use by the federal Food and Drug Administration in 2002. We are trying to determine the clinical situations in which it is best to use these microspheres, Vallow says.

The therapy uses millions of tiny polymer beads − each one of which is about one-third the diameter of a human hair − which contain the radioactive element yttrium-90. An interventional radiologist uses a catheter to infuse the microspheres directly into the hepatic artery, which supplies all the blood to the liver. There the beads deliver radiation directly to tumors for about 11 days.

In this study, data from 20 patient procedures using microspheres at Mayo Clinic Jacksonville were analyzed. The entire liver was treated in 75 percent of the cases, and in the remaining 25 percent, either the left or right lobe of the liver was selectively targeted. Four weeks after treatment, researchers used CT scans to assess response of tumors, and found that in 71 percent, tumors decreased in size. The tumors were smaller or less active with less contrast uptake on follow-up CT scans, Vallow says.

The majority of patients had minimal side effects from the treatment, she says. Cancer progressed in two patients and they died within three months. But for the patients who responded, by the end of a 10-month follow-up period, no new tumors were detected, Vallow says. Liver function tests in the responding patients have become normal or have stabilized.

The researchers say the treatment works best in patients that have good blood flow to their tumors. Further evaluation with longer follow-up will help clarify the benefit of this novel treatment, Vallow says.


'/>"/>
Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
2. Bacteria Commonly Seen In Radioactive Waste, Hot Springs Found Inside Humans
3. Brain Cancer Could be Safely Treated with Radioactive Scorpion Venom
4. Chornobyl Incident Proved Increased Risk of Thyroid Cancer from Radioactive Iodine
5. Adult COPD or asthma could be effectively treated with Xopenex
6. CPR! How Effectively is it being done ?
7. Using Cholesterol Lowering Drugs Effectively
8. Older Breast Cancer Patients Can Be Effectively Treated With Chemotherapy
9. Fungal Infections Effectively Controlled By Light Therapy
10. Elderly People Needs To Tackle The Heat Effectively
11. Treating Autism More Effectively
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... CareAcademy, ... that it has raised $1.675 M in seed funding to further expand its ... and Techstars Venture Capital Fund are the company’s primary investors. , ...
(Date:8/17/2017)... ... , ... Centrifugation is more than just spinning. Like a car in our ... do without. And just like a car, there are a few points to consider ... will learn about the most important safety aspects while using a centrifuge, as well ...
(Date:8/16/2017)... ... , ... The next Patient Care Academy at Kalamazoo Valley Community College begins ... the seven-week long Patient Care Academy are eligible to take the State of Michigan ... CNA in Kalamazoo is $24,428.* , As a CNA, one is equipped for employment ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, the leading ... was acquired by Advantage Solutions. The Data Council’s IX-ONE platform is the ... industry’s leading suppliers, brokers, distributors and retailers. The Data Council will become a ...
(Date:8/16/2017)... ... August 16, 2017 , ... QualDerm Partners , ... development, today announced Cumberland Skin Surgery and Dermatology has joined the ... offices in both Hermitage and Lebanon, Tennessee, provides comprehensive general dermatology and skin ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... GAITHERSBURG, Md. , Aug. 7, 2017 /PRNewswire/ ... for healthcare member acquisition, retention, and engagement, announced ... Director of Strategy and Product Development, effective as ... strategic consulting and technology implementation strategy for our ... years of experience in consulting and business analytics ...
(Date:8/7/2017)... 7, 2017  Endo International plc (NASDAQ: ... resolve virtually all known U.S. mesh product liability claims ... the known remaining U.S. claims at reasonable values. Under ... the fourth quarter of 2017 and continuing through the ... quarter 2017 results, the Company intends to increase its ...
(Date:8/2/2017)... , Aug. 2, 2017 Fenita ... Who as a Pinnacle Lifetime Professional in the ... Account Manager at Turing Pharmaceuticals, AG. Her skills ... and relationship building.                ... than 25 years of experience as a highly ...
Breaking Medicine Technology: